Volume 25, Issue 10, Pages (October 2017)

Slides:

Advertisements

Similar presentations

Structure and Activity of Strigolactones: New Plant Hormones with a Rich Future Binne Zwanenburg, Tomáš Pospíšil Molecular Plant Volume 6, Issue 1, Pages.

Advertisements

Duplex Ultrasound Evaluation of Lower Extremity Venous Insufficiency Robert J. Min, MD, Neil M. Khilnani, MD, Piyush Golia Journal of Vascular and Interventional.

Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review X.-F. Gao, Z.-W. Yang, J. Li International.

Genetic Engineering and Manufacturing of Hematopoietic Stem Cells

Volume 20, Issue 2, (February 2012)

414. A Novel Clinical Severity Scoring Measure in Canine X-Linked Myotubular Myopathy: Results Following Systemic AAV Gene Replacement Molecular Therapy

209. Use of Helicobacter pyroli Neutrophil Activating Protein (NAP) as an Immune- Modulatory Agent To Enhance the Efficacy of Oncolytic Adenovirus Therapy.

Untangling P-Bodies: Dissecting the Complex Web of Interactions that Enable Tiered Control of Gene Expression Christopher J. Kershaw, Mark P. Ashe Molecular.

Man's Best Friend: Utilizing Naturally Occurring Tumors in Dogs to Improve Chimeric Antigen Receptor T-cell Therapy for Human Cancers Melinda Mata, Stephen.

Engineering Natural Killer Cells for Cancer Immunotherapy

Pichamol Jirapinyo, Christopher C. Thompson

162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo

Has the 6-Min Walk Distance Run Its Course?

Molecular Therapy Volume 20, Pages S261-S262 (May 2012) DOI: /S (16)

Stem Cell Therapies in Clinical Trials: Progress and Challenges

Evolving Gene Therapy in Primary Immunodeficiency

Volume 25, Issue 4, Pages (April 2017)

Engineering Natural Killer Cells for Cancer Immunotherapy

Escaping the Valley of Death

Volume 26, Issue 2, Pages (February 2018)

Giorgia Santilli, Adrian J. Thrasher Molecular Therapy

Volume 25, Issue 1, Pages 5-7 (January 2017)

FAQS and facts about clinical trials and ethical errors

Volume 25, Issue 5, Pages (May 2017)

Volume 17, Issue 1, Pages 3-12 (March 2010)

1060. The MSCV_U3 Internal Promoter Strongly Activates Surrounding Cellular Promoter in Combination with Self_Inactivating (SIN)_MSCV Vector Backbone

Untangling P-Bodies: Dissecting the Complex Web of Interactions that Enable Tiered Control of Gene Expression Christopher J. Kershaw, Mark P. Ashe Molecular.

Premal Lulla, Carlos A. Ramos Molecular Therapy

Molecular Therapy Volume 20, (May 2012) DOI: /S (16)

Molecular Therapy Volume 7, Issue 5, (May 2003) DOI: /S (16)

News & Notes Journal of Allergy and Clinical Immunology

Patient-Reported Outcomes of Cirrhosis

847. Eradication of Therapy-Resistant Human Prostate Tumors Using an Ultrasound Guided Site-Specific Cancer Terminator Virus Delivery Approach Molecular.

Volume 49, Issue 4, Pages v-vi (October 2018)

Designer Lipids Advance Systemic siRNA Delivery

Volume 25, Issue 5, Pages (May 2017)

Volume 4, Issue 5, Pages 2-3 (October 2006)

660. Bowel/Bladder Sensation and Control in Patients with Spinal Cord Injury Treated with Human Embryonic Stem Cell Therapy Geeta Shroff Molecular Therapy

Editorial Board Orthopedic Clinics Volume 48, Issue 3, (July 2017)

Editorial Board Orthopedic Clinics Volume 47, Issue 3, (July 2016)

Volume 26, Issue 2, Pages (February 2018)

68. Site Specific Intra-Placental Gene Transfer Corrects Fetal Growth Restriction in a Novel Mouse Model of Placental Insufficiency (PI) Molecular.

521. Multiplex Genome Editing of TCR°/CD52 Genes as a Platform for “Off the Shelf” Adoptive T-Cell Immunotherapies Molecular Therapy Volume 22, Pages.

Volume 13, Pages S217-S218 (January 2006)

405. Hindlimb and Forelimb Strength Assessment in a Canine Model of X-Linked Myotubular Myopathy Following AAV-Mediated Gene Replacement Molecular.

Volume 26, Issue 4, Pages (April 2018)

674. Molecular, Biochemical and Biomechanical Analysis of Articular Cartilage Repaired with Genetically Modified Chondrocytes Expressing Insulin-Like.

Clinical Trials of Adenovirus-mediated Therapy for Glioma

Daniel E. Abbott, MD Surgical Oncology Clinics

Molecular Therapy Volume 18, Pages S260-S261 (May 2010) DOI: /S (16)

Simon M. Glynn, MD, Sean J. Pittock, MD, Steven A. Vernino, MD, PhD

Volume 156, Issue 5, Pages (April 2019)

In This Issue Molecular Therapy Volume 16, Issue 4, (April 2008)

News & Notes Journal of Allergy and Clinical Immunology

Vitamin D in chronic kidney disease: is the jury in?

Giorgia Santilli, Adrian J. Thrasher Molecular Therapy

Volume 9, Issue 5, (October 2011)

773. Detection of RNA Interference (RNAi) Mediated mRNA Cleavage in Fresh Injected Tumor Tissue from Patients in a Phase I Trial of pbi-shRNA™ Lipoplex.

740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells Molecular Therapy Volume 20, Pages S285-S286.

Molecular Therapy Volume 21, Pages S247-S248 (May 2013)

Issue Highlights Clinical Gastroenterology and Hepatology

History of Oncolytic Viruses: Genesis to Genetic Engineering

86. A Highly Compact Epitope-Based Marker Suicide Gene for Safer and Easier Adoptive T-Cell Gene Therapy Molecular Therapy Volume 20, Pages S35-S36.

Volume 25, Issue 4, Pages (April 2017)

Editorial Board Orthopedic Clinics Volume 47, Issue 2, (April 2016)

Volume 163, Issue 2, (October 2015)

Medical Therapy for Refractory Pediatric Crohn’s Disease

Volume 50, Issue 2, Pages iii-iv (April 2019)

News & Notes Journal of Allergy and Clinical Immunology

624. Randomized Phase II Trial of Adjuvant Autologous Tumor Cell Vaccine (FANG™) for High Risk Stage III/IV Ovarian Cancer: Preliminary Results Molecular.

Presentation transcript:

Volume 25, Issue 10, Pages 2235-2237 (October 2017) Unfounded Claims of Improved Functional Outcomes Attributed to Follistatin Gene Therapy in Inclusion Body Myositis Steven A. Greenberg Molecular Therapy Volume 25, Issue 10, Pages 2235-2237 (October 2017) DOI: 10.1016/j.ymthe.2017.09.002 Copyright © 2017 Terms and Conditions

Figure 1 Study Design Does Not Allow for Conclusions of Efficacy for Follistatin Gene Therapy (A) Study design and its relationship to clinical trial NCT01519349. (B) Hypothetical design in which 3 of the 4 interventions are controlled through blinding and use of a comparator group. 6MWT, 6-min walk test Molecular Therapy 2017 25, 2235-2237DOI: (10.1016/j.ymthe.2017.09.002) Copyright © 2017 Terms and Conditions